Vertical farming project parent company enters administration

Reading Time: minute By Susan Edmunds for RNZ Hamilton business Greenleaf Fresh is being put into voluntary administration, after what it says were “recent financial challenges” affecting the company’s operations, it announced in late December. Greenleaf Fresh is behind Greengrower, a vertical farm operation that received $3.5 million in public funding in 2023 for research.…

30th December 2024-5th January 2025

Adroit Pharmaceuticals Pvt. Ltd. Through Its Director Sanjay Kukreja Vs. Amit Poddar Resolution Professional & Ors., Company Appeal (AT) (Insolvency) No. 1274 of 2024 Super Floorings Pvt. Ltd. Vs. Napin Impex Ltd., Company Appeal (AT) (Insolvency) No. 1928 of 2024 & I.A. No.7115 of 2024 Mr. Tajinder Singh Bhathal vs. MRF Limited & Ors., Company…

Access Denied

Access Denied You don’t have permission to access “http://www.businesswire.com/news/home/20250105406020/en/Acticor-Biotech-announces-its-liquidation-proceedings” on this server. Reference #18.84f23717.1736159008.9b02092 https://errors.edgesuite.net/18.84f23717.1736159008.9b02092 Read the original article here

From billion-rand valuation to liquidation

VAST Networks, once valued at over R1 billion, was shut down in 2019 after failing to turn a profit. Founded in 2014 as a joint venture between Dimension Data and Naspers, the company aimed to provide carrier-grade Wi-Fi across Southern Africa. Despite significant investment and expansion, VAST struggled to monetize its services. After unsuccessful sale…

Analysing NCLAT’s Ruling On Sub-Classification Of Operational Creditors – Insolvency/Bankruptcy

The recent judgment by the National Company Law Appellate Tribunal (NCLAT) in NCC Ltd. v. Golden Jubilee Hotels Pvt. Ltd.1 sheds light on the treatment of operational creditors under the Insolvency and Bankruptcy Code, 2016 (IBC). This ruling emphasizes the evolving judicial perspective regarding the categorization and sub-classification of operational creditors, highlighting the need for…

Acticor Biotech announces its liquidation proceedings

PARIS, January 06, 2025–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announced today that the Paris Commercial Court, has declared on January 2, the company in liquidation proceedings. The liquidator is Marc-Antoine Rey, SELARL BDR & Associés, 34 rue…